Riskpilot← Back to searchSign inGet full accessCR ORTOLAB ApS
APSActiveCVR 36020105Sct Hansgade 25, 1.Manufacture of medical and dental instruments and supplies · NACE 3250Est. 20142 employees
Revenue 2025
DKK 1,5M
-12% vs 2024
EBITDA margin
11.0%
-68% vs 2024
Equity ratio
51.6%
Financial strength
Net profit 2025
DKK 118K
-68% vs 2024
| Revenue | DKK 1,5M | -12% |
| EBITDA | DKK 169K | -68% |
| Net profit | DKK 118K | -68% |
| Total assets | DKK 728K | -15% |
| Equity | DKK 376K | -33% |
| Employees | 2 | — |
Legal name
CR ORTOLAB ApS
CVR number
36020105
Legal form
Anpartsselskab
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
24. juni 2014
Share capital
DKK 94.323
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er fremstilling af medicinske og dentale instrumenter samt udstyr hertil.
Address
Sct Hansgade 25, 1.
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.472 | 1.224 | 1.261 | 966 | 803 | 1.129 | 815 | 908 | 1.182 | 1.379 | 1.731 | 1.530 |
| Staff expenses | -877 | -613 | -694 | -779 | -736 | -724 | -713 | -846 | -851 | -1.120 | -1.208 | -1.336 |
| EBITDA | 0 | 221 | 567 | 187 | 67 | 405 | 102 | 62 | 331 | 259 | 523 | 169 |
| Depreciation & amort. | -163 | -165 | -178 | -174 | -100 | -6 | -17 | -33 | -35 | -32 | -34 | -11 |
| EBIT | -162 | 56 | 389 | 13 | -32 | 399 | 85 | 29 | 297 | 227 | 489 | 158 |
| Net financials | -18 | -17 | -7 | -15 | -1 | 0 | 2 | -2 | -3 | -8 | -8 | -4 |
| Profit before tax | -180 | 39 | 382 | -2 | -34 | 399 | 87 | 27 | 294 | 219 | 481 | 153 |
| Tax | -49 | 9 | 86 | 5 | -6 | 92 | 21 | 4 | 69 | 51 | 107 | 35 |
| Net profit | -132 | 30 | 295 | -7 | -28 | 307 | 66 | 23 | 225 | 168 | 374 | 118 |
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 686 | 673 | 774 | 575 | 262 | 569 | 439 | 338 | 638 | 668 | 855 | 728 |
| Equity | 200 | 230 | 424 | 314 | 195 | 401 | 267 | 190 | 415 | 333 | 558 | 376 |
| Long-term debt | 256 | 192 | 129 | 73 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 177 | 187 | 182 | 178 | 68 | 168 | 172 | 148 | 223 | 334 | 298 | 353 |
| Total debt | 432 | 379 | 311 | 251 | 68 | 168 | 172 | 148 | 223 | 334 | 298 | 353 |
EBITDA margin
11.0%
This company
15.8%
Market median
-30% vs market
20142025
Equity ratio
51.6%
This company
38.2%
Market median
+35% vs market
20142025
Return on equity
31.4%
This company
18.4%
Market median
+71% vs market
20142025
Net profit margin
7.7%
This company
8.1%
Market median
-5% vs market
20142025
Asset turnover
2.10×
This company
1.12×
Market median
+87% vs market
20142025
Debt / equity
0.94×
This company
0.62×
Market median
+52% vs market
20142025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
CV Management | Management | 2014 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Charthom Holding ApS | Company | 100.0% | 100.0% | 2018 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Charthom Holding ApS
CR ORTOLAB ApS Board members of CR ORTOLAB ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Charlotte Vangsgaard Riisberg | Management | 0 companies |